It’s hard to go wrong dining out in the Big Easy, a city with rich culinary traditions. But if you’re not comfortable leaving things to chance, check out our restaurant recommendations before heading out for a bite.

The American Diabetes Association is pulling back the curtain on its annual updates to the ADA Standards of Care at the 82nd Scientific Sessions. “We will share how we work with new data that have been published recently to adjust the standards,” said Vanita R. Aroda, MD, a member of the ADA Professional Practice Committee.

“Heart failure has been a forgotten disorder because the basic and translational science models were created with atherosclerosis in diabetes leading to ischemic heart attacks and strokes. But if you look at the real world, people with diabetes develop heart failure and their mortality is horrific,” said Eldrin F. Lewis, MD, MPH.

Two symposia on the first day of the Scientific Sessions will review the latest findings and new treatment strategies to mitigate cardiac and kidney disease in diabetes. “Our patients cross the boundaries between cardiology and diabetes, and we have to do the same to co-manage them more effectively,” said Suzanne V. Arnold, MD, MHA.

“What’s unique about these new classes of drugs is that they’re not glucose-lowering drugs. They’re cardio-renal risk-reducing agents that happen to lower glucose if your kidney function is normal or reasonable,” said George Bakris, MD.

Despite its negative impact on quality of life, diabetic peripheral neuropathy (DPN) remains undertreated, with only half of individuals receiving analgesic treatment and only 28% of them using anticonvulsants or antidepressants, according to Loretta Vileikyte, MD, PhD (left), who will discuss the psychosocial impact of painful DPN. Stephanie Eid, PhD, will discuss efforts to develop…

There’s a lot of misinformation and conflicting advice about healthy eating habits. Maureen Chomko, RD, CDCES, and Alison Evert, MS, RDN, CDCES, will help Scientific Sessions attendees clear up the confusion so they can have quality conversations about nutrition with their patients.

There’s no shortage of things to do or sights to see in New Orleans, site of the 82nd Scientific Sessions. Founded by the French and later ruled by the Spanish, this one-of-a-kind city is jam-packed with European, Southern, Creole, and Cajun influences.

The stage is set for the 82nd Scientific Sessions in New Orleans, with a robust program featuring 139 invited speaker sessions, 370 oral presentations, and more than 1,000 poster and e-poster presentations covering the hottest topics, latest research discoveries, and emerging trends in diabetes research, prevention, and care. Virtual participation is also an option for…

The ADA and the European Association for the Study of Diabetes will release the latest consensus recommendations on managing hyperglycemia in type 2 diabetes during a special joint session co-chaired by ADA Chief Scientific and Medical Officer Robert A. Gabbay, MD, PhD (left), and EASD President Stefano Del Prato, MD.